Rabeprazole Sodium
Product Images NDC 45865-802

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 45865-802). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (802)

This appears to be a description of a medication called "Rabeprazole Sodium DR" that comes in tablet form at a 20mg dosage strength. The prescription label indicates that it should be taken twice daily, and the packaging includes 30 tablets per package. The origin or manufacturer of the medication is not specified.*

FDA Label Image

Image-01 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 01)

FDA Label Image

Image-02 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 02)

This is a chart that displays heartburn scores for a study conducted on a placebo group, a group taking 10mg of RAB, and a group taking 20mg of RAB. The study lasted 28 days and scored heartburn levels from 0 (none) to 4 (very severe).*

FDA Label Image

Image03 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 03)

The text provides a table with the mean score for three different conditions: placebo, RAB 10mg, and RAB 20mg. It also includes a scale for heartburn scores, where 0 represents no heartburn. No additional information or context is available to provide a more specific description.*

FDA Label Image

Image-04 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 04)

The text describes a study with two groups, a placebo group (n=58) and another group receiving RAB20mg (n=59). There are some numbers listed below these groups, which seem to refer to days of study. Additionally, there is a description of Heartoum scores, which ranges from 0 (None) to 4 (Very Severe). No additional information is available to provide a more specific description of the study.*

FDA Label Image

Image05 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 05)

This is a table displaying the mean heartburn scores for two groups of people, one group receiving a placebo (n=58) and the other group receiving RAB20mg (n=59), over a period of 28 days. The heartburn scores range from 0 to 4 and are rated as 0 = No heartburn, 1 = Mild, 2 = Moderate, 3 = Severe, 4 = Very Severe.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.